These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 32209185)

  • 1. [Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients].
    Zhao H; Chen J
    Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):168-175. PubMed ID: 32209185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary pulmonary lymphoepithelioma-like carcinoma.
    Fan Y; Li C; Qin J; Lu H
    Med Oncol; 2020 Mar; 37(3):20. PubMed ID: 32146584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pulmonary lymphoepithelioma-like carcinoma is characterized by high PD-L1 expression, but low tumor mutation burden.
    Wu Q; Wang W; Zhou P; Fu Y; Zhang Y; Shao YW; Jiang L
    Pathol Res Pract; 2020 Aug; 216(8):153043. PubMed ID: 32703503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Lymphoepithelioma-like Carcinoma.
    Sathirareuangchai S; Hirata K
    Arch Pathol Lab Med; 2019 Aug; 143(8):1027-1030. PubMed ID: 30672338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Real-world Study on the Assessment of Pathological Characteristics and Targeted Therapeutic Effect of Non-small Cell Lung Cancer Patients with Positive Driving Genes and High PD-L1 Expression].
    Zhang H; Yang X; Li K; Wang J; Lv J; Li X; Zhang X; Qin N; Zhang Q; Wu Y; Ma L; Gai F; Hu Y; Zhang S
    Zhongguo Fei Ai Za Zhi; 2021 Feb; 24(2):78-87. PubMed ID: 33478196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation Study on Expression of PD-1 and PD-L1 in Non-small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations].
    Jiang L; Lin Z; Li N; Jiang J; Lu C; Du S; Zhang J; Wang Y; Chen J; Gong P
    Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):623-631. PubMed ID: 34455737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma: A systematic review and meta-analysis.
    Tang L; Chen N; He W; Zhou J; Zhang J; Lin Z; Wang Z; Hao J; Lin F
    PLoS One; 2020; 15(10):e0240729. PubMed ID: 33064745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
    Fan Y; Shan Q; Gong J; Qin J; Lu H
    Front Mol Biosci; 2021; 8():736940. PubMed ID: 34760925
    [No Abstract]   [Full Text] [Related]  

  • 9. PD-L1 score as a prognostic biomarker in asian early-stage epidermal growth factor receptor-mutated lung cancer.
    Saw SPL; Ng WP; Zhou S; Lai GGY; Tan AC; Ang MK; Lim WT; Kanesvaran R; Ng QS; Jain A; Tan WL; Rajasekaran T; Chan JWK; Teh YL; Pang M; Yeo JC; Takano A; Ong BH; Tan EH; Tan SH; Skanderup AJ; Tan DSW
    Eur J Cancer; 2023 Jan; 178():139-149. PubMed ID: 36436331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.
    Ng TL; Liu Y; Dimou A; Patil T; Aisner DL; Dong Z; Jiang T; Su C; Wu C; Ren S; Zhou C; Camidge DR
    Cancer; 2019 Apr; 125(7):1038-1049. PubMed ID: 30548240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up.
    Liang Y; Wang L; Zhu Y; Lin Y; Liu H; Rao H; Xu G; Rong T
    Cancer; 2012 Oct; 118(19):4748-58. PubMed ID: 22359203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of PD-1, PD-L1, ALK, and ROS1 proteins expression in non-small cell lung carcinoma patients from Egypt.
    Bahnassy AA; Ismail H; Mohanad M; El-Bastawisy A; Yousef HF
    J Egypt Natl Canc Inst; 2022 May; 34(1):23. PubMed ID: 35644823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy.
    Chang YL; Yang CY; Lin MW; Wu CT; Yang PC
    Lung Cancer; 2015 Jun; 88(3):254-9. PubMed ID: 25862146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival.
    Fang W; Hong S; Chen N; He X; Zhan J; Qin T; Zhou T; Hu Z; Ma Y; Zhao Y; Tian Y; Yang Y; Xue C; Tang Y; Huang Y; Zhao H; Zhang L
    Oncotarget; 2015 Oct; 6(32):33019-32. PubMed ID: 26361045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between PD-L1 expression and driver gene mutations in non-small cell lung cancer patients: correlation with clinical data.
    Karatrasoglou EA; Chatziandreou I; Sakellariou S; Stamopoulos K; Kavantzas N; Lazaris AC; Korkolopoulou P; Saetta AA
    Virchows Arch; 2020 Aug; 477(2):207-217. PubMed ID: 31989260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics and cancer-specific prognosis of primary pulmonary lymphoepithelioma-like carcinoma: a population study of the US SEER database and a Chinese hospital.
    Zhang Q; Dai Y; Jin L; Shi S; Liu C; Rong R; Sun W; Dai S; Kong H; Xie W
    Front Oncol; 2023; 13():1103169. PubMed ID: 37274245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark.
    Dalvi T; Nørgaard M; Fryzek JP; Movva N; Pedersen L; Pham Hansen H; Walker J; Midha A; Shire N; Boothman AM; Rigas J; Mellemgaard A; Rasmussen TR; Hamilton-Dutoit S; Cronin-Fenton D
    PLoS One; 2023; 18(4):e0284037. PubMed ID: 37040387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers.
    Liam CK; Yew CY; Pang YK; Wong CK; Poh ME; Tan JL; Soo CI; Loh TC; Chin KK; Munusamy V; Liam YS; Ibrahim NH
    BMC Cancer; 2023 Jul; 23(1):659. PubMed ID: 37452277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary pulmonary lymphoepithelioma-like carcinoma in Singapore.
    Tay CK; Chua YC; Takano A; Min Chee MY; Lim WT; Lim C; Koh MS
    Ann Thorac Med; 2018; 13(1):30-35. PubMed ID: 29387253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non-small cell lung cancer negative for EGFR mutation and ALK fusion.
    Sakai H; Takeda M; Sakai K; Nakamura Y; Ito A; Hayashi H; Tanaka K; Nishio K; Nakagawa K
    Lung Cancer; 2019 Jan; 127():59-65. PubMed ID: 30642552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.